Silence Therapeutics plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Silence Therapeutics plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 27.77K shares, a 98.03% decline from fiscal 2024.
- Silence Therapeutics plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 1.41M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 27.77K shares 10-K · filed 2026-03-05 | |
| 2024-12-31 | 1.41M shares 10-K · filed 2025-02-27 |